Cargando…

Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial

OBJECTIVE: To consider the effects of whole-grain processing, specifically milling, on glycemic control in free-living adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants of this crossover trial were randomized to two interventions of 2 weeks, separated by washout. They were advis...

Descripción completa

Detalles Bibliográficos
Autores principales: Åberg, Sebastian, Mann, Jim, Neumann, Silke, Ross, Alastair B., Reynolds, Andrew N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372063/
https://www.ncbi.nlm.nih.gov/pubmed/32424022
http://dx.doi.org/10.2337/dc20-0263
_version_ 1783561235348848640
author Åberg, Sebastian
Mann, Jim
Neumann, Silke
Ross, Alastair B.
Reynolds, Andrew N.
author_facet Åberg, Sebastian
Mann, Jim
Neumann, Silke
Ross, Alastair B.
Reynolds, Andrew N.
author_sort Åberg, Sebastian
collection PubMed
description OBJECTIVE: To consider the effects of whole-grain processing, specifically milling, on glycemic control in free-living adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants of this crossover trial were randomized to two interventions of 2 weeks, separated by washout. They were advised to replace the grain foods they normally consumed with intervention foods. Intervention foods were nutrient-matched whole-grain products of wheat, oats, and brown rice that differed in their degree of processing. No other lifestyle advice was given. Continuous glucose monitoring systems were worn. Other cardiometabolic risk factors and alkylresorcinols (a biomarker of whole-grain intake) were measured pre- and postintervention. RESULTS: Thirty-one adults with type 2 diabetes (63 ± 13 years old, BMI 32.4 ± 7 kg/m(2), HbA(1c) 7.5 ± 3.4% [59 ± 14 mmol/mol]) commenced the trial; 28 (90%) completed both interventions. The increase in alkylresorcinols did not differ between interventions, and there was no difference in reported energy intake. Postprandial responses were 9% (95% CI 3–15) lower following breakfast and 6% (1–10) lower following all meals of less-processed whole grains when compared with finely milled grains. Day-long glycemic variability also was reduced when measured by 24-h SD (−0.16 mmol/L [95% CI −0.25 to −0.06]) and mean amplitude of glycemic excursion (−0.36 [95% CI −0.65 to −0.08]). Mean change in body weight differed by 0.81 kg (95% CI 0.62–1.05) between interventions, increasing during the finely milled intervention and decreasing during the less-processed whole-grain intervention. This was not a mediating factor for the glycemic variables considered. CONCLUSIONS: Consuming less-processed whole-grain foods over 2 weeks improved measures of glycemia in free-living adults with type 2 diabetes compared with an equivalent amount of whole-grain foods that were finely milled. Dietary advice should promote the consumption of minimally processed whole grains.
format Online
Article
Text
id pubmed-7372063
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-73720632020-07-24 Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial Åberg, Sebastian Mann, Jim Neumann, Silke Ross, Alastair B. Reynolds, Andrew N. Diabetes Care Clinical Care/Education/Nutrition/Psychosocial Research OBJECTIVE: To consider the effects of whole-grain processing, specifically milling, on glycemic control in free-living adults with type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants of this crossover trial were randomized to two interventions of 2 weeks, separated by washout. They were advised to replace the grain foods they normally consumed with intervention foods. Intervention foods were nutrient-matched whole-grain products of wheat, oats, and brown rice that differed in their degree of processing. No other lifestyle advice was given. Continuous glucose monitoring systems were worn. Other cardiometabolic risk factors and alkylresorcinols (a biomarker of whole-grain intake) were measured pre- and postintervention. RESULTS: Thirty-one adults with type 2 diabetes (63 ± 13 years old, BMI 32.4 ± 7 kg/m(2), HbA(1c) 7.5 ± 3.4% [59 ± 14 mmol/mol]) commenced the trial; 28 (90%) completed both interventions. The increase in alkylresorcinols did not differ between interventions, and there was no difference in reported energy intake. Postprandial responses were 9% (95% CI 3–15) lower following breakfast and 6% (1–10) lower following all meals of less-processed whole grains when compared with finely milled grains. Day-long glycemic variability also was reduced when measured by 24-h SD (−0.16 mmol/L [95% CI −0.25 to −0.06]) and mean amplitude of glycemic excursion (−0.36 [95% CI −0.65 to −0.08]). Mean change in body weight differed by 0.81 kg (95% CI 0.62–1.05) between interventions, increasing during the finely milled intervention and decreasing during the less-processed whole-grain intervention. This was not a mediating factor for the glycemic variables considered. CONCLUSIONS: Consuming less-processed whole-grain foods over 2 weeks improved measures of glycemia in free-living adults with type 2 diabetes compared with an equivalent amount of whole-grain foods that were finely milled. Dietary advice should promote the consumption of minimally processed whole grains. American Diabetes Association 2020-08 2020-05-18 /pmc/articles/PMC7372063/ /pubmed/32424022 http://dx.doi.org/10.2337/dc20-0263 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license.
spellingShingle Clinical Care/Education/Nutrition/Psychosocial Research
Åberg, Sebastian
Mann, Jim
Neumann, Silke
Ross, Alastair B.
Reynolds, Andrew N.
Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
title Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
title_full Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
title_fullStr Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
title_full_unstemmed Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
title_short Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial
title_sort whole-grain processing and glycemic control in type 2 diabetes: a randomized crossover trial
topic Clinical Care/Education/Nutrition/Psychosocial Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372063/
https://www.ncbi.nlm.nih.gov/pubmed/32424022
http://dx.doi.org/10.2337/dc20-0263
work_keys_str_mv AT abergsebastian wholegrainprocessingandglycemiccontrolintype2diabetesarandomizedcrossovertrial
AT mannjim wholegrainprocessingandglycemiccontrolintype2diabetesarandomizedcrossovertrial
AT neumannsilke wholegrainprocessingandglycemiccontrolintype2diabetesarandomizedcrossovertrial
AT rossalastairb wholegrainprocessingandglycemiccontrolintype2diabetesarandomizedcrossovertrial
AT reynoldsandrewn wholegrainprocessingandglycemiccontrolintype2diabetesarandomizedcrossovertrial